In a move that underscores how far Ayurveda has come from being a traditional remedy to a global wellness force, Kapiva Ayurveda Raises $60 Million in Series D funding. This marks one of the largest investments ever for an Ayurvedic startup in India. The round was led by 360 ONE Asset and Vertex Growth, with repeat support from Vertex Ventures Southeast Asia & India and 3one4 Capital. Early backer Fireside Ventures partially exited, cashing in on the brand’s rapid scale. Of the total funding, $28 million entered as primary capital while the rest gave investors a profitable secondary exit.
Founded in 2015 by Ameve Sharma and Shrey Badhani, Kapiva has steadily built a reputation for taking Ayurveda out of dusty textbooks and packaging it into scientifically validated, modern-day solutions. Today, its portfolio spans diabetes care, liver and digestive health, sports nutrition, and even hormonal balance. It’s no surprise the brand resonates with India’s young, urban crowd who are tired of quick fixes and seeking preventive healthcare.
Currently, the company clocks an annual revenue run rate of ₹550 crore, a massive leap from ₹350 crore in FY25, sustaining 80%+ year-on-year growth for three straight years. With over 500 employees, a presence in 40,000 retail outlets across India, and expanding footprints in the US, UK, and UAE, Kapiva now plans to pump this fresh funding into R&D, scaled manufacturing, brand-building, and digital health-tech bets.
This raise isn’t just about Kapiva. It signals something bigger: investors are now betting heavily on Ayurveda’s global relevance. India’s preventive healthcare market is projected to touch ₹3.21 lakh crore by 2032, and Kapiva is gearing up to ride that wave while pushing toward profitability.
1. Introduction: Kapiva Ayurveda Raises $60 Million
Kapiva’s latest funding round isn’t just another startup headline, it’s a loud endorsement of Ayurveda’s shift into mainstream consumer health. Kapiva Ayurveda Raises $60 Million in its Series D, spearheaded by 360 ONE Asset and Vertex Growth, reflecting investor faith in evidence-driven wellness brands that are now strong enough to compete with global nutraceutical players.
2. Background of Kapiva Ayurveda
2.1 Founding Story
Kapiva was born in 2015 when Ameve Sharma, scion of the Baidyanath Ayurveda legacy, teamed up with Shrey Badhani, a Bain & Co consultant turned entrepreneur. Their goal was bold yet simple: make Ayurveda relevant to millennials and Gen Z by marrying traditional formulations with scientific credibility.
2.2 The Journey So Far
What began as a direct-to-consumer experiment quickly evolved into a brand spanning online marketplaces, offline stores, and health-tech integrations. Today, Kapiva sells over 100 SKUs ranging from juices and gummies to powders and capsules. The product strategy is clear target chronic conditions and daily wellness concerns while speaking the language of modern lifestyles.
2.3 Milestones Achieved
From a fledgling D2C startup, Kapiva now employs 500+ professionals, serves millions, and has become a ₹550 crore ARR company. Its meteoric growth highlights one thing: when Ayurveda is backed with clinical validation, consumers listen.
3. Funding and Capital Structure
3.1 Series D Funding Details
September 2025 saw Kapiva close its $60 million Series D. Out of this, $28 million was primary capital for aggressive growth, while the rest facilitated a profitable Fireside Ventures exit.
3.2 Previous Funding Rounds
This round follows Kapiva’s $10 million raise in 2024 from OrbiMed Asia. With this fresh infusion, the startup’s total fundraising now exceeds $90 million placing it among the best-backed names in Ayurveda wellness.
3.3 Use of Funds
The new cash will go into three high-priority areas:
- Building a personalised health-tech ecosystem.
- Strengthening R&D and scaling manufacturing.
- Doubling down on brand-building and global expansion.
4. Working Model of Kapiva
4.1 Direct-to-Consumer Strategy
Kapiva thrives on a hybrid model. Its website and online marketplaces push D2C sales, while over 40,000 offline retail stores cement nationwide presence.
This dual approach ensures both reach and credibility consumers can discover the brand online and find the same products at their local chemist or supermarket. It also helps Kapiva gather rich consumer data from digital sales while scaling trust through offline visibility.
4.2 Health-Tech Integration
What sets Kapiva apart is its digital-first approach. The brand is developing tools that track consumer health, connect users to Ayurvedic doctors, and recommend tailored product journeys, pushing Ayurveda firmly into the health-tech era.
4.3 Consumer Segments
The primary customer base? Millennials and Gen Z, wellness-conscious, urban, tech-savvy, and increasingly inclined toward preventive healthcare. This group is willing to experiment with Ayurveda, provided it comes with scientific validation and convenience. Kapiva’s messaging, packaging, and digital outreach are crafted to appeal to this audience, positioning it as both modern and trustworthy.
5. Revenue Model
5.1 Revenue Streams : Kapiva earns from:
- Product sales (juices, capsules, powders, gummies).
- Online doctor consultations and health-tech services.
- International operations, now contributing 5–10% of total revenue.
Beyond these streams, Kapiva leverages its D2C model to gain higher margins and collects data to refine product offerings. The health-tech component also opens avenues for subscription-based services and personalized wellness plans, creating recurring revenue opportunities.
5.2 Financial Performance
In FY25, the company touched ₹550 crore ARR, compared to ₹350 crore in FY24. That’s a massive jump for a wellness brand that’s only a decade old. Such rapid growth reflects strong consumer trust, omnichannel reach, and the increasing appetite for evidence-backed Ayurvedic solutions. It also positions Kapiva as one of the fastest-growing players in India’s wellness sector.
5.3 Profitability Outlook
While still slightly EBITDA negative, Kapiva projects profitability by Q4 FY26, banking on scale and global sales. Operational efficiencies, expanded international footprint, and stronger brand recognition are expected to drive margins upward. Experts see this as a case study in how modern Ayurveda can turn profitability while staying true to holistic wellness principles.
6. Product Portfolio and Services
6.1 Categories Offered
Kapiva’s range includes:
- Diabetes and hypertension solutions
- Liver and digestive health
- Sports nutrition and energy boosters
- Hormonal balance and daily wellness
- Skincare and immunity enhancers
Beyond these, the brand continuously experiments with functional beverages, herbal supplements, and wellness gummies tailored to urban lifestyles. Each product category is backed by a focus on preventive care, aiming to address modern health challenges rather than just treating symptoms. This diverse portfolio ensures Kapiva appeals to millennials and Gen Z who value convenience, efficacy, and authenticity in wellness products.
6.2 Innovation Through Science
Unlike traditional Ayurvedic giants, Kapiva actively invests in clinical trials and evidence-led product development. This commitment has earned it modern credibility.
The company also collaborates with nutritionists, healthcare professionals, and research labs to validate formulations. By merging ancient wisdom with scientific rigor, Kapiva creates products that resonate with health-conscious consumers seeking both tradition and trustworthiness in their daily wellness routines.
7. Industry Context and Growth Trends
7.1 Ayurveda Market Growth
India’s Ayurvedic market is projected to hit ₹3.21 lakh crore by 2032, fueled by a growing preference for preventive wellness and natural therapies. This surge isn’t just about heritage; it reflects an evolving consumer mindset that increasingly favors holistic solutions over quick-fix medications. Urban wellness seekers are demanding transparency, clinical backing, and convenience trends Kapiva is actively tapping into.
7.2 Global Opportunities
Kapiva has already established subsidiaries in the US, UK, and UAE, aiming to tap diaspora communities and premium consumers abroad. With wellness tourism, e-commerce, and rising health awareness, global markets present massive potential. The brand’s strategy is to merge authentic Ayurvedic offerings with modern delivery channels, making traditional wellness accessible and aspirational for international audiences.
7.3 Impact of Preventive Healthcare
Urban Indians, particularly millennials, are increasingly investing in nutrition, supplements, and fitness. This consumer mindset aligns perfectly with Kapiva’s mission. Preventive healthcare isn’t just a trend; it’s becoming a lifestyle. By focusing on chronic condition management, daily wellness, and personalized guidance, Kapiva positions itself as a partner in long-term health rather than just a product vendor.
8. Competitor Landscape
Kapiva faces competition on two fronts: new-age Ayurvedic startups like Innovacare, Gynoveda, and Wellbeing Nutrition, and legacy FMCG giants such as Dabur, Patanjali, and Himalaya. What sets Kapiva apart is its focus on scientific validation and health-tech integration, offering consumers not just traditional Ayurveda, but a modern, credible, and evidence-backed wellness experience. This combination of innovation and trust gives it a unique edge in a crowded market.
9. Founders and Leadership
Kapiva is steered by Ameve Sharma, who draws on the Baidyanath legacy to champion science-backed Ayurveda, and Shrey Badhani, whose Bain & Co experience brings strategic and operational rigor. In 2025, the promotion of COO Shantanu and CRO Anuj Sharma to co-founders further solidified the leadership team, adding depth and execution strength to drive Kapiva’s ambitious growth plans.
10. Global Expansion Plans
Kapiva is taking Ayurveda beyond India, setting up subsidiaries in the US, UK, and UAE to tap into diaspora communities and premium health-conscious consumers. While the international strategy leans on e-commerce and digital-first engagement, scaling globally comes with hurdles, regulatory compliance, local partnerships, and complex supply chains must all be managed carefully to sustain growth.
Key Points:
- Subsidiaries in US, UK, UAE contributing 5–10% of revenue.
- Target audience: diaspora, premium consumers, wellness-conscious millennials.
- E-commerce and health-tech platforms central to international strategy.
- Challenges: regulatory hurdles, supply chain management, and local partnerships.
- Focus on maintaining brand credibility and product quality abroad.
11. Challenges in Ayurveda Wellness
11.1 Consumer Skepticism
Even with Ayurveda’s centuries-old legacy, there’s an undeniable streak of doubt among today’s health-conscious buyers. Many wonder if herbal remedies actually deliver the promised results. Kapiva tackles this head-on, not by just invoking tradition, but by fusing it with hard science.
11.2 Market Competition
The wellness industry is a battlefield. Nimble startups pop up almost daily with trendy innovations, while established FMCG giants lean on their massive reach and brand clout. Kapiva doesn’t play by either rulebook. Instead, it carves its own path, marrying Ayurvedic wisdom with rigorous scientific proof. The result? A distinct identity that resonates with those who refuse to settle for either blind tradition or soulless corporatism.
11.3 Supply Chain and Compliance
International growth means adhering to stringent quality norms a costly but necessary effort. Kapiva doesn’t just pay lip service to compliance, they throw resources, time, and relentless attention into quality control and exhaustive product testing. It’s not about checking boxes; it’s about making sure that whether you’re in India, the US, or the UAE, the product works exactly as promised. No shortcuts. No compromises. The brand’s integrity rides on it, and Kapiva knows that a misstep anywhere could ripple across markets.
12. Learning for Startups and Entrepreneurs
Kapiva’s journey underscores the power of blending tradition with innovation. Startups can learn that credibility, customer trust, and consistent quality often matter more than flashy campaigns or rapid scaling alone. Kapiva’s journey proves a few things:
- Blending heritage with science creates trust.
- Omnichannel beats single-channel.
- Global expansion needs compliance muscle.
- Persistence in brand-building pays off.
The core lesson? Solve a real consumer problem first, then scale sustainably.
About Foundlanes
At Foundlanes, we see Kapiva’s $60 million raise as more than just a deal. It’s a symbol of how Indian startups are taking heritage industries and making them globally competitive. Expect more such stories as the startup ecosystem matures and Ayurveda reclaims the spotlight on the world stage.